Ledger.Open graph →
SEC Form D · filed March 30, 2021

Chemomab Therapeutics Ltd

Offering
$45.4M
Sold
$45.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
TEL AVIV, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Claude C. Nicaise · Cheshire, CTDirectorNeil H. Cohen · Cambridge, MADirectorNissim C. Darvish · Tel Aviv, L3DirectorStephen P. Squinto · New York, NYDirectorDean Delisle · Macclenny, FLDirectorLarry Braden · Macclenny, FLDirectorAdi Mor George · Tel Aviv, L3Exec · DirectorArnon Aharon · Ness Ziona, L3ExecJoel M. Maryles · Hashmonaim, L3DirectorSigal Fatal · Ramat Gan, L3ExecMoses C. Alan · Tel Aviv, L3DirectorWhitney Imeraj · Atlanta, GADirectorAnthony Cox · Atlanta, GADirectorAdi Mor George · Tel Aviv, L3Exec · DirectorArnon Aharon · Tel Aviv, L3ExecJoel M. Maryles · Hashmonaim, L3DirectorNissim C. Darvish · Tel Aviv, L3DirectorSigal Fatal · Ramat Gan, L3ExecStephen P. Squinto · New York, NYDirectorMoses C. Alan · Tel Aviv, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗